About Us
Overview
Our Vision & Values
Milestones
Leadership
Awards & Recognition
CSR
Our Business
Overview
Formulations
Biologics
APIs
Research
Overview
Formulations
APIs
R&D Locations
Manufacturing
Investors
Financials and Reports
Share, Governance and Investor Services
Offer Documents
Disclosures Under Regulation 46 of SEBI (LODR) Regulations
Shareholders’ Information
Media
Care
Careers
Newsroom
Contact Us
Filings
Emcure Material Creditors
Emcure Material Creditors
Financials of Material Subsidiaries
Gennova Biopharmaceuticals Limited Financials March 2024
Zuventus Healthcare Limited Financials March 2024
Emcure UK INR Converted Financials FY 2024
Marcan INR Converted Finacials FY 2024
Tillomed UK INR Converted Financial FY 2024
Gennova Biopharmaceuticals Ltd. – Financia Statement 2023
Gennova Biopharmaceuticals Ltd. – Financia Statement 2022
Gennova Biopharmaceuticals Ltd. – Financia Statement 2021
Zuventus Healthcare Ltd – Financia Statement 2023
Zuventus Healthcare Ltd – Financia Statement 2022
Zuventus Healthcare Ltd – Financia Statement 2021
Emcure UK INR Converted Financial
Tillomed UK INR Converted Financial
Marcan INR Converted Financial
Annual Returns
Emcure Pharmaceuticals – Annual Return 2024
Emcure Pharmaceuticals – Annual Return 2023
Emcure Pharmaceuticals – Annual Return 2022
Emcure Pharmaceuticals – Annual Return 2021
Emcure Pharmaceuticals – Annual Return 2020
Emcure Pharmaceuticals – Annual Return 2019
Top Five Group Companies Data
Top Five Group Companies
Financials of the Company
Emcure Pharmaceuticals Limited Conso Financials March 2024
Emcure Pharmaceuticals Limited Financials March 2024
EPL Financials March 2023
EPL Financials March 2022
EPL Financials March 2021
Quarterly Financials
Quarterly Financials – Q3 FY25
Quarterly Financials – Q2 FY25
Quarterly Financials – Q1 FY25
Quick Explore
About Us
Career
Contact Us
Manufacturing
Newsroom
Our Business
Research
